Cipla is currently trading at Rs. 601.20, up by 0.85 points or 0.14% from its previous closing of Rs. 600.35 on the BSE.
The scrip opened at Rs. 601.00 and has touched a high and low of Rs. 608.00 and Rs. 600.05 respectively. So far 8,643 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 663.00 on 07-Nov-2017 and a 52 week low of Rs. 479.00 on 26-May-2017.
Last one week high and low of the scrip stood at Rs. 622.00 and Rs. 597.20 respectively. The current market cap of the company is Rs. 48,385.00 crore.
The promoters holding in the company stood at 37.26%, while Institutions and Non-Institutions held 37.49% and 25.25% respectively.
Cipla’s subsidiary - Cipla Holding B.V., has entered into an agreement to sell its 100% equity stake in Cipla Croatia d.o.o., Croatia to PharmaS d.o.o., Croatia in order to align with company’s strategy to operate via a B2B model in Europe. The transaction is expected to be closed within 45 days from Effective Date i.e. November 30, 2017.
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1525.00 |
Dr. Reddys Lab | 5942.65 |
Cipla | 1345.35 |
Zydus Lifesciences | 925.95 |
Lupin | 1547.05 |
View more.. |